168 related articles for article (PubMed ID: 10451876)
1. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunodetection of colorectal carcinoma.
Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
[TBL] [Abstract][Full Text] [Related]
3. Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Bohdiewicz PJ; Scott GC; Juni JE; Fink-Bennett D; Wilner F; Nagle C; Dworkin HJ
Clin Nucl Med; 1995 Mar; 20(3):230-6. PubMed ID: 7750217
[TBL] [Abstract][Full Text] [Related]
4. [Indium 111-labeled antibodies in the detection of colorectal carcinoma].
Artiko V; Obradović V; Davidović B; Petrović N; Petrović M; Krivokapić Z; Pavlov M; Adanja G; Sobić D; Vlajković M; Pavlović S; Rebić R
Acta Chir Iugosl; 2003; 50(4):43-6. PubMed ID: 15307496
[TBL] [Abstract][Full Text] [Related]
5. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
Doerr RJ; Herrera L; Abdel-Nabi H
Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
[TBL] [Abstract][Full Text] [Related]
6. Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.
Perkins AC; Vincent RM; Wastie ML; Denton GW; Amar S; Hardcastle JD
Nucl Med Commun; 1994 Dec; 15(12):981-90. PubMed ID: 7715898
[TBL] [Abstract][Full Text] [Related]
7. Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma.
Markowitz A; Saleemi K; Freeman LM
Clin Nucl Med; 1993 Aug; 18(8):685-700. PubMed ID: 8403703
[TBL] [Abstract][Full Text] [Related]
8. Oncoscint for detection of disseminated colorectal and ovarian cancer.
Med Lett Drugs Ther; 1993 Jun; 35(898):52-3. PubMed ID: 8497207
[No Abstract] [Full Text] [Related]
9. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
[TBL] [Abstract][Full Text] [Related]
10. In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma.
Neal CE; Baker MR; Hilgers RD; Fanning J; Burke RC; Snodgrass J; Cull RD
Clin Nucl Med; 1993 Jun; 18(6):472-6. PubMed ID: 8319398
[TBL] [Abstract][Full Text] [Related]
11. OncoScint image atlas.
Maguire RT
Targeted Diagn Ther; 1992; 6():141-75. PubMed ID: 1576344
[No Abstract] [Full Text] [Related]
12. Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
Abdel-Nabi HH; Doerr RJ
Targeted Diagn Ther; 1992; 6():73-88. PubMed ID: 1576351
[TBL] [Abstract][Full Text] [Related]
13. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ
J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995
[TBL] [Abstract][Full Text] [Related]
14. OncoScint CR103 imaging in the surgical management of patients with colorectal cancer.
Doerr RJ; Abdel-Nabi HH
Targeted Diagn Ther; 1992; 6():89-109. PubMed ID: 1576352
[No Abstract] [Full Text] [Related]
15. Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.
Collier BD; Abdel-Nabi H; Doerr RJ; Harwood SJ; Olsen J; Kaplan EH; Winzelberg GG; Grossman SJ; Krag DN; Mitchell EP
Radiology; 1992 Oct; 185(1):179-86. PubMed ID: 1523304
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoguided surgery.
Veroux G; Nicosia AS; Veroux P; Cardillo P; Veroux M; Amodeo C
Hepatogastroenterology; 1999; 46(30):3099-108. PubMed ID: 10626169
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of In-111 satumomab pendetide immunoscintigraphy. An aid to visual interpretation of images in patients with suspected carcinomatosis.
Neal CE; Johnson DL; Cornwell VL; Markwell S
Clin Nucl Med; 1996 Aug; 21(8):638-42. PubMed ID: 8853918
[TBL] [Abstract][Full Text] [Related]
18. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up.
Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z
Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193
[TBL] [Abstract][Full Text] [Related]
19. Multicenter clinical trial of 111In-CYT-103 in patients with ovarian cancer.
Gallup DG
Targeted Diagn Ther; 1992; 6():111-24. PubMed ID: 1576342
[No Abstract] [Full Text] [Related]
20. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
